| Revenue growth | Q4 revenue grew 3% YoY; FY26 revenue grew 7% YoY. |
|---|---|
| Margins | Margins impacted by Roha capitalization, input cost inflation, and unfavorable project mix. |
| Order book | Engineering order book at INR 26,433 million as of March 31, 2026. |
| Demand visibility | Healthy enquiry pipeline driven by medium-sized opportunities across various sectors. |
| Management confidence | Positive on long-term chemical segment outlook despite temporary West Asia headwinds. |
Growth
FY26 revenue grew 7% to INR 29,148 million; however, EBITDA fell 29% to INR 2,102 million due to higher costs.
Outlook
Engineering order book stands at INR 26,433 million. Management expects Roha plant utilization to reach 25-30% in FY27.
Risks
West Asia crisis caused INR 60 crore export deferrals and increased raw material costs (styrene, oleum).
Last quarter's promises, checked
Delivered
- Guided Roha cation stream commissioning → Delivered cation stream stabilized (= BEAT)
- Guided 3rd Quarter order inflow → Delivered INR 5,160 million (= BEAT)
Partly delivered
- Guided Roha capacity utilization ramp-up → Delivered 40-45% commissioned but utilization very low (= PARTIAL)
Missed
- Guided better execution/profitability in Engineering → Delivered 28% EBIT decline (= MISS)
- Guided international project execution in Q3 → Delivered deferral to Q4 (= MISS)
Earnings Call filed with NSE, NSE: IONEXCHANG. Summary written with AI assistance from the document.
Ion Exchange (India) Ltd: key numbers
- Share price
- ₹326.05
- Market cap
- ₹4,782 Cr
- Revenue (annual)
- ₹2,915 Cr
- Net profit (annual)
- ₹142.7 Cr
- P/E (TTM)
- -147.1×Sector 21.7×
- Promoter holding
- 25.08%-0.35% QoQ
- FII holding
- 4.93%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Ion Exchange (India) Ltd
All →Ion Exchange (India) Earnings Call Transcript: Key Takeaways
Q2 FY27 EBITDA loss of ₹848 Mn and net loss of ₹828 Mn on ~8% revenue decline. Legacy-project overrun booked in one go. H2 recovery depends on deferred dispatches and the Hyundai order.
Ion Exchange (India) Investor Presentation: Key Takeaways
Q2 FY27 consolidated operating loss: operating income INR 6,747 Mn (-8.1% YoY), EBITDA INR (848) Mn, PAT INR (828) Mn, driven by legacy project cost revisions.
Ion Exchange (India) Management Change
Ion Exchange's board approved redesignating Executive Chairman Rajesh Sharma as Non-Executive Non-Independent Chairman, effective 1 January 2027. The change needs shareholder approval via postal ballot.
Ion Exchange (India) Q2 FY27 Results: Net Loss of ₹82.8 Cr
Ion Exchange (India) Ltd reported revenue from operations of ₹674.7 Cr (-8.1% YoY) and a net loss of ₹82.8 Cr for Q2 FY27.
- Key figure
- Net loss ₹82.8 Cr
Ion Exchange (India) Board Meeting Date
Ion Exchange India gave prior intimation of a November 3, 2026 board meeting to consider unaudited Q2 and H1 results. The filing is a future meeting notice with no results figures attached.
Ion Exchange (India) Other Announcement
Ion Exchange (India) Limited has filed its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI regulation 31(1)(b).